Humacyte Inc (NAS:HUMA)
$ 0.71 -0.0063 (-0.9%) Market Cap: 190.80 Mil Enterprise Value: 208.16 Mil PE Ratio: 0 PB Ratio: 13.61 GF Score: 23/100

Humacyte Inc at TD Cowen Healthcare Conference Transcript

Mar 4, 2026 / 03:30 PM GMT
Release Date Price: $1.15 (+7.48%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HUMA.OQ - Humacyte Inc
Humacyte Inc at TD Cowen Healthcare Conference
Mar 04, 2026 / 03:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning. We're getting towards the end of the morning, but, we're actually middle of the morning. Sorry, I'm Josh Jennings from the TD Cowan Medical Research Medical Devices Research team, and, we are excited to have executives from Humasite in our midst, in our presence, multi-year participant.

Thank you guys for supporting the conference and especially this year. It's the. We have, CEO, President, and founder, Doctor Laura Nicholson, and, CFO Dale Sanders is here as well, but I'm going to hand it over to Laura to run through the human site story and, get us up to speed on an exciting regenerative medicine technology. Laura, thanks so much for coming in this year.

---------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot